Asarfi Hospital Ltd
Incorporated in 2005, Asarfi Hospital Ltd
provides primary health services & treatment
and specialized super speciality health service[1]
- Market Cap ₹ 230 Cr.
- Current Price ₹ 117
- High / Low ₹ 122 / 52.8
- Stock P/E 20.9
- Book Value ₹ 41.4
- Dividend Yield 0.00 %
- ROCE 16.2 %
- ROE 14.5 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 33.1% CAGR over last 5 years
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 47.2 days to 93.2 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
43 | 54 | 65 | 69 | 81 | 121 | |
37 | 46 | 54 | 55 | 65 | 97 | |
Operating Profit | 6 | 8 | 11 | 14 | 16 | 24 |
OPM % | 15% | 15% | 17% | 20% | 20% | 20% |
0 | 0 | 1 | 2 | 2 | 8 | |
Interest | 1 | 1 | 1 | 1 | 3 | 4 |
Depreciation | 2 | 3 | 3 | 4 | 9 | 13 |
Profit before tax | 4 | 5 | 8 | 11 | 6 | 15 |
Tax % | 27% | 26% | 26% | 26% | 33% | 25% |
3 | 4 | 6 | 8 | 4 | 11 | |
EPS in Rs | 21.48 | 28.83 | 46.79 | 5.53 | 2.14 | 5.58 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 23% |
TTM: | 49% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 33% |
3 Years: | 24% |
TTM: | 161% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 67% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 14% |
Last Year: | 14% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 1 | 1 | 1 | 14 | 20 | 20 |
Reserves | 12 | 16 | 21 | 27 | 51 | 62 |
5 | 7 | 12 | 17 | 32 | 49 | |
9 | 13 | 28 | 34 | 52 | 34 | |
Total Liabilities | 28 | 37 | 63 | 93 | 154 | 164 |
18 | 22 | 31 | 39 | 94 | 101 | |
CWIP | 0 | 2 | 9 | 18 | 0 | 2 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 |
9 | 13 | 22 | 37 | 60 | 61 | |
Total Assets | 28 | 37 | 63 | 93 | 154 | 164 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
2 | 10 | 9 | 7 | 26 | -4 | |
-5 | -16 | -23 | -21 | -63 | -8 | |
2 | 6 | 14 | 15 | 36 | 13 | |
Net Cash Flow | 0 | 0 | -0 | 1 | -1 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 20 | 14 | 30 | 90 | 109 | 120 |
Inventory Days | 23 | 13 | 16 | 26 | 32 | 30 |
Days Payable | 156 | 23 | 34 | 91 | 445 | 171 |
Cash Conversion Cycle | -113 | 5 | 11 | 25 | -304 | -20 |
Working Capital Days | 18 | -7 | -4 | 52 | -3 | 93 |
ROCE % | 25% | 29% | 26% | 11% | 16% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
1d - Asarfi Hospital partners with Gleneagles to launch Jharkhand's first multi-organ transplant unit in Dhanbad.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
14 May - Asarfi Hospital reports 43% revenue growth, 47% EBITDA rise, cancer hospital expansion, and FY27 growth vision.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
12 May - Disclosure of investor meet outcome; no unpublished price sensitive information shared.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 May - We have scheduled a conference call with analyst/investors on Monday, May 12, 2025, at 16:00 PM InST, inter alia, to discuss the Audited financial results …
-
Announcement under Regulation 30 (LODR)-Investor Presentation
9 May - Investor Presentation of the company for the quarter and year ended March 31, 2025.
Annual reports
Concalls
-
May 2025Transcript PPT
-
Jan 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
Business Overview Asarfi Hospital Limited (AHL) operates three primary facilities:
Pharmacy Contribution: The hospital’s pharmacy contributed 25% of the revenue
Asarfi Cancer Institute (Ranguni, Dhanbad)[2]
Future Expansion: The facility is approved for construction of up to seven floors, enabling substantial expansion.
Research Institute (Ranchi)[3]